Icahn Enterprises L.P. logo

Icahn Enterprises L.P. (IEP)

Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
6. 81
+0.01
+0.1471%
After Hours
$
6. 87
+0.06 +0.8811%
4.57B Market Cap
- P/E Ratio
4% Div Yield
485,568 Volume
0.93 Eps
$ 6.8
Previous Close
Add Transaction
Day Range
6.77 6.83
Year Range
6.51 9.32
Want to track IEP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

IEP closed today higher at $6.81, an increase of 0.1471% from yesterday's close, completing a monthly decrease of -12.6923% or -$0.99. Over the past 12 months, IEP stock lost -9.8013%.
IEP pays dividends to its shareholders, with the most recent payment made on Jun 25, 2026. The next announced payment will be in In 3 weeks on Sep 23, 2026 for a total of $0.5.
The last earnings report, released on May 05, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0394%, based on the last three reports.
Icahn Enterprises L.P. has completed 1 stock splits, with the recent split occurring on Jan 05, 2012.
The company's stock is traded on one exchange.

IEP Chart

People also search for

Kratos Defense & Security Solutions, Inc.
$ 49.34
-3.2169%
Tetra Tech, Inc.
$ 35.74
-1.1068%
Saia, Inc.
$ 331.62
-6.6201%
DBX
Dropbox Inc.
$ 34.26
-2.6428%
AAL
American Airlines Group Inc.
$ 12.95
-3.5741%
Arbor Realty, Icahn Enterprises and Herzfeld: 3 Unconventional High Yield Bets

Arbor Realty, Icahn Enterprises and Herzfeld: 3 Unconventional High Yield Bets

Income investors chasing double-digit yields keep bumping into the same wall: Eye-popping payouts sit inside unusual structures with idiosyncratic risks.

247wallst | 1 week ago
Icahn Enterprises Q2 Earnings Call Highlights

Icahn Enterprises Q2 Earnings Call Highlights

Icahn Enterprises NASDAQ: IEP reported a second-quarter 2026 net loss attributable to the company of $355 million, or $0.52 per depositary unit, compared with a $165 million loss, or $0.30 per unit, a year earlier. Adjusted EBITDA attributable to IEP was a loss of $134 million, compared with adjusted EBITDA of $40 million in the prior-year quarter.

Marketbeat | 3 weeks ago
Icahn Enterprises L.P. (IEP) Q2 2026 Earnings Call Prepared Remarks Transcript

Icahn Enterprises L.P. (IEP) Q2 2026 Earnings Call Prepared Remarks Transcript

Icahn Enterprises L.P. (IEP) Q2 2026 Earnings Call Prepared Remarks Transcript

Seekingalpha | 3 weeks ago

Icahn Enterprises L.P. Investors

Name Quantity Cost Value Profit ($) Gain (%)
BZ
Brandon Zatopek Commonwealth Equity Services LLC
25,617 $184,697 $191,102.82 $6,405.82 3.47%
NA
Nizar Araji National Bank Of Canada /FI/
40,100 $299,506 $298,945.5 -$560.5 -0.19%
Jeff Ameen
Jeff Ameen Spire Wealth Management
5,500 $59,650.02 $42,845 -$16,805.02 -28.17%
CAL
CoreCap Advisors LLC CoreCap Advisors LLC
10 $81.78 $77.9 -$3.88 -4.74%
CB
Catherine Bluvol Next Level Private LLC
40,030 $288,616.3 $311,833.7 $23,217.4 8.04%

Icahn Enterprises L.P. (IEP) FAQ

What is the stock price today?

The current price is $6.81.

On which exchange is it traded?

Icahn Enterprises L.P. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is IEP.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 4%.

What is its market cap?

As of today, the market cap is 4.57B.

Has Icahn Enterprises L.P. ever had a stock split?

Icahn Enterprises L.P. had 1 splits and the recent split was on Jan 05, 2012.

Icahn Enterprises L.P. Profile

Industrial Conglomerates Industry
Industrials Sector
Ted Papapostolou CEO
NASDAQ (NGS) Exchange
451100101 CUSIP
US Country
13,562 Employees
17 Aug 2026 Last Dividend
13 Nov 2012 Last Split
18 May 1987 IPO Date

Overview

Icahn Enterprises L.P. is a diversified conglomerate with a wide range of businesses in the investment, energy, automotive, food packaging, real estate, home fashion, and pharmaceutical sectors. Operating both in the United States and internationally, the company engages in a variety of operations through its subsidiaries. It not only invests proprietary capital through private investment funds but also offers advisory and related services. Founded in 1987, Icahn Enterprises is headquartered in Sunny Isles Beach, Florida, reflecting its substantial growth and diversified expansion since its incorporation.

Products and Services

  • Investment

    This segment focuses on investing the company's proprietary capital through various private investment funds. In addition to direct investments, it offers investment advisory and other related services.

  • Energy

    In the energy sector, Icahn Enterprises refines and markets transportation fuels such as gasoline and diesel fuels, along with renewable diesel. Furthermore, the company is involved in manufacturing nitrogen fertilizers, specifically urea ammonium nitrate and ammonia, contributing to the agricultural sector.

  • Automotive

    This segment encompasses the sale of automotive parts and materials, retail merchandise, as well as providing automotive repair and maintenance services. It also includes the leasing of real estate properties dedicated to automotive uses.

  • Food Packaging

    Operating in the food industry, this segment produces and sells various types of casings for processed meat products, including cellulosic, fibrous, and plastic variations. These products are essential for the packaging and preparation of processed meats.

  • Real Estate

    The real estate operations of Icahn Enterprises involve leasing land, retail, office, and industrial properties. Additionally, the segment engages in the development and sale of single-family homes and the operation of country clubs, showcasing a broad real estate portfolio.

  • Home Fashion

    This segment deals with the manufacturing, sourcing, marketing, distribution, and sales of home fashion consumer products, encompassing a wide range of items for home decoration and utility.

  • Pharma

    Icahn Enterprises extends its operations to the pharmaceutical sector, offering products and services that include the development and distribution of pharmaceutical goods, highlighting the conglomerate’s versatility and reach in various industries.

Contact Information

Address: 16690 Collins Avenue
Phone: 305 422 4100